SANCAK, B. Et Al. 2013. Evaluation of vancomycin and daptomycin MIC trends for methicillin-resistant Staphylococcus aureus blood isolates over an 11 year period. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.68, no.11 , 2689-2691.

SANCAK, B., Yagci, S., Mirza, H. C., & Hascelik, G., (2013). Evaluation of vancomycin and daptomycin MIC trends for methicillin-resistant Staphylococcus aureus blood isolates over an 11 year period. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.68, no.11, 2689-2691.

SANCAK, BANU Et Al. "Evaluation of vancomycin and daptomycin MIC trends for methicillin-resistant Staphylococcus aureus blood isolates over an 11 year period," JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.68, no.11, 2689-2691, 2013

SANCAK, BANU Et Al. "Evaluation of vancomycin and daptomycin MIC trends for methicillin-resistant Staphylococcus aureus blood isolates over an 11 year period." JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.68, no.11, pp.2689-2691, 2013

SANCAK, B. Et Al. (2013) . "Evaluation of vancomycin and daptomycin MIC trends for methicillin-resistant Staphylococcus aureus blood isolates over an 11 year period." JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.68, no.11, pp.2689-2691.

@article{article, author={BANU SANCAK Et Al. }, title={Evaluation of vancomycin and daptomycin MIC trends for methicillin-resistant Staphylococcus aureus blood isolates over an 11 year period}, journal={JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY}, year=2013, pages={2689-2691} }